Galderma recently announced that the full results from the Phase III OLYMPIA 1 trial, which evaluated the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis, were published…
Oxford Nanopore Technologies, a leader in advanced nanopore-based molecular sensing technology, has announced a groundbreaking collaboration with UK Biobank to create the world’s first large-scale, comprehensive epigenetic dataset. Utilizing Oxford…
The Menarini Group, a global leader in pharmaceuticals and diagnostics, along with its subsidiary Stemline Therapeutics, will present new and expanded data on ORSERDU® (elacestrant) at the 2024 San Antonio…
HCA Healthcare, Inc. (NYSE:HCA), one of the largest healthcare providers in the United States, proudly announced the success of its sixth annual “Crush the Crisis” national prescription drug take-back day,…
The BioFuture™ 2024 conference, organized by Demy-Colton, concluded in New York and virtually, marking the largest turnout in the event’s history. This year’s conference brought together more than 100 speakers,…
Rigaku Corporation, a global leader in X-ray analytical equipment and a member of the Rigaku Holdings Group, has officially opened the Rigaku Bioscience Laboratory in Cambridge, Massachusetts. Rigaku Corporation has…
Laekna, Inc. (2105.HK), a global biotech company focused on developing novel therapies for metabolic and cancer diseases, is excited to announce a clinical collaboration with Eli Lilly and Company (Lilly),…
Pharmanovia, a global pharmaceutical company focused on commercializing innovative medicines and revitalizing established ones, today announced the expansion of its oncology portfolio with a new licensing agreement for catumaxomab. This…
Lobe Sciences, Ltd. (CSE: LOBE, OTCQB: LOBEF) and Alera Pharma, Inc. today announced the receipt of a second patent allowance for their Conjugated Psilocin™ technology. The patent, titled “Stable Psilocin…
Cancer Targeted Technology (CTT), a Seattle-based biotechnology company focused on cancer diagnostics and therapies, announced that the National Cancer Institute has awarded the Phase I portion ($400K) of a fast-track…
Universal Health Services (UHS) (NYSE: UHS) has been named a Champion of Board Diversity by The Forum of Executive Women, the leading women’s organization in the Greater Philadelphia Region. This…
Meridian Health Plan of Illinois, a provider of managed care services for children, families, and individuals with complex medical needs, has expanded its telehealth program with Blueberry Pediatrics. Initially launched…